Synthesis of the Heptadecapeptide corresponding to the Full Sequence of Dynorphin

スポンサーリンク

概要

• 論文の詳細を見る

• The synthesis of a heptadecapeptide corresponding to the amino acid sequence of dynorphin, H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-OH, using the 4-methoxy-2,6-dimethylbenzenesulfonyl (Mds) group for the protection of the guanidino function of arginine, is described. To synthesize dynorphin, three peptide fragments corresponding to residues, 1-3,4-10,11-17,were prepared and used as building blocks for the final construction of the full sequence of this opioid peptide. Final deprotection of the fully protected peptide was achieved by treatment with 0.15M methanesulfonic acid in trifluoroacetic acid-thioanisole at room temperature for 1 h and the purification was effected by column chromatography on carboxymethyl (CM)-cellulose and by preparative high performance liquid chromatography (HPLC). The synthetic heptadecapeptide was compared with purified natural dynorphin by means of reverse-phase HPLC and found to be identical with natural dynorphin.

• 社団法人日本薬学会の論文
• 1982-07-25

著者

• 藤野 政彦

  Pharmaceutical Research Division Takeda Chemical Industries Ltd.

• 藤野 政彦

  武田薬品工業

• 藤野 政彦

  Chemistry Laboratories Central Research Division Takeda Chemical Industries Ltd.

• 藤野 政彦

  武田薬品中央研

• 北田 千恵子

  Chemical Research Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.

• 藤野 政彦

  武田薬品工業(株)

• 北田 千恵子

  Discovery Research Division Takeda Chemical Industries Ltd.

• Kitada Chieko

  Discovery Research Division Takeda Chemical Industries Ltd

• 脇舛 光広

  Chemistry Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.

• 脇舛 光広

  Chemistry Laboratories Central Research Division Takeda Chemical Industries Ltd.

関連論文

• 医薬品としてのペプチドおよびタンパク質 (タンパク質化学の新展開)
• Studies on Peptides. LXXIII. Examination of the Methanesulphonic Acid Procedure for the Synthesis of Peptides containing Methionine
• Studies on Peptides. CXXXIV. : Evaluation of S-1-Adamantylcysteine for Peptide Synthesis
• The Synthesis of Serum Thymic Factor and Its Analogs
• Synthesis and Pharmacology of TRH Analogs to separate Central Nervous Action from Endocrine Activity
• Synthesis of Salmon Endorphin
• Studies on Peptides. LXXX. N^G-Mesitylene-2-sulfonylarginine
• New Method for Removing the S-p-Methoxybenzyl and S-t-Butyl Groups of Cysteine Residues with Mercuric Trifluoroacetate
• Studies on Peptides. LX. Synthesis of the Nonatriacontapeptide corresponding to the Entire Amino Acid Sequence of Bovine Adrenocorticotropic Hormone
• p-Methoxybenzenesulfonyl as a Protecting Group of Guanidino Function in Peptide Synthesis
• Synthesis of Peptides related to Corticotropin (ACTH). IX. Application of N-Hydroxy-5-norbornene-2,3-dicarboximide Active Ester Procedure to the Synthesis of Human Adrenocorticotropic Hormone (α_h-ACTH)
• Synthesis of Peptides related to Corticotropin (ACTH). VIII. Synthesis of α^-ACTH
• The Use of N-Hydroxy-5-norbornene-2,3-dicarboximide Active Esters in Peptide Synthesis
• Isobornyloxycarbonyl Function, a New Convenient Amino-Protecting Group in Peptide Synthesis. I. Synthesis and Properties of Isobornyloxycarbonylamino Acids
• Synthesis of Peptides related to Corticotropin (ACTH). VII. Syntheses and Biological Activity of Leucine^7-α^-ACTH and N^α-Methyltryptophan^9-α^-ACTH
• Synthesis of Peptides Related to Corticotropin (ACTH). VI. Syntheses and Biological Activity of the Peptides Corresponding to the Amino Acid Sequences 4-23,5-23,6-24 and 7-23 in ACTH
• Synthesis of Peptides related to Corticotropin (ACTH). V. Syntheses of Leucine^4- and Isoleucine^4-α^-ACTH
• Synthesis of Peptides related to Corticotropin (ACTH). IV. Syntheses of β-Alanine^1-, γ-Aminobutyric Acid^1-, Sarcosine^1-, Proline^1- and Lysine^1-α^-ACTH
• Synthesis of Peptides related to Corticotropin (ACTH). III. Syntheses of α^_2-ACTH and β-Alanine^1-α^_2-ACTH
• Synthesis of Peptides related to Corticotropin (ACTH). I. Synthesis of α^_2-ACTH-tricosapeptide Amide
• Synthesis of Peptides related to Corticotropin (ACTH). II. Synthesis of the Protected Peptides Corresponding to the Sequence 1-3,4-6,7-10,11-14,15-19 and 20-23 of ACTH
• The Use of Esters of Simple Ketoximes in Peptide Synthesis
• 蛋白およびペプチド性医薬品の開発における諸問題
• LOCALIZATION OF PROLACTIN - RELEASING PEPTIDE (PrRP) IN THE RAT BRAIN ; ESPECIALLY IN RELATION TO OXYTOCIN NEURONS
• Synthesis of Some Di-and Tri-Substituted Analogs of Luteinizing Hormone Releasing Hormone (LH-RH)
• Isobornyloxycarbonyl Function, a New Convenient Amino-Protecting Group in Peptide Synthesis.IV. Synthesis of Gonadotropin-Releasing Hormone (Gn-RH or LH-RH/FSH-RH)
• DETECTION OF THE NEW APPEARANCE OF PROLACTIN-RELEASING PEPTIDE (PrRP)-PRODUCING CELLS IN THE AREA POSTREMA OF THE RAT MEDULLA OBLONGATA
• Synthesis and Biological Activity of 8-L-Ala-Motilin and 8-D-Ala-Motilin
• Application of an Automated Synthesis Suite to Parallel Solution-Phase Peptide Synthesis
• Solution-Phase Automated Synthesis of Tripeptide Derivatives
• Novel LH-RH Receptor Antagonists ; Design, Synthesis, and Antagonistic Activities of Cyclic Pentapeptides
• Synthesis of Granuliberin-R and Various Fragment Peptides and Their Histamine-Releasing Activities
• A New Mast Cell Degranulating Peptide "Mastoparan" in the Venom of Vespula lewisii
• Synthesis of the Dodecapeptide Amide corresponding to the Entire Amino Acid Sequence of Granuliberin-R, a New Frog Skin Peptide from Rana rugosa
• Synthesis of Granuliberin-R, a New Frog Skin Peptide from Rana rugosa
• A Solution-Phase Synthesis of Fragment Peptide Derivatives Using an Automated Synthesis Apparatus
• Application of a Unique Automated Synthesis System for Solution-phase Peptide Synthesis
• 最近の生理活性ペプチド研究--立体構造と作用機作を中心に (アミノ酸・核酸)
• 4-Methoxy-2,3,6-trimethylbenzenesulfonyl (Mtr) : a New Amino and Imidazole Protecting Group in Peptide Synthesis
• Synthesis of the Heptadecapeptide corresponding to the Full Sequence of Dynorphin
• Further Studies on the Use of Multi-substituted Benzenesulfonyl Groups for Protection of the Guanidino Function of Arginine
• Use of the 4-Methoxy-2,6-dimethylbenzenesulfonyl (Mds) Group to Synthesize Dynorphin [1-13] and Related Peptides
• 29 担子菌酵母,Tremella mesentericaの接合管形成誘導物質
• 1B-12 Saccharomyces kluyveriの性フェロモン, 特にSaccharomyces cerevisiaeの性フェロモンとの関連性
• 生理活性ペプチドの合成--構造-活性相関を中心として (アミノ酸・核酸特集)
• Synthesis of the Carboxy Terminal Fragments of the β-Subunit of the Human Chorionic Gonadotropin(hCG)
• 1 Tremella mesenterica の接合管誘導物質,tremerogen A-10の化学構造と,合成類縁体の生物活性
• New Peptide Models for Studying Racemization
• Synthesis of the Nonacosapeptide corresponding to Mammalian Glucagon
• Synthesis of Porcine Motilin and Its D-Phe^1-Analog by the Use of Methanesulfonic Acid
• High Potency Analogs of Apelin, A Ligand of Orphan GPCR APJ
• GALP, a Novel Galanin-like Peptide Found in Porcine Hypothalamus : Isolation and cDNA Cloning
• Synthesis of New Peptides with Prolactin-releasing Activity by a Combination of Recombinant DNA Technology and a Cysteine-specific Cyanylation Reaction
• Identification of Prolactin-Releasing Peptide
• Synthesis of New Peptides with Prolactin-releasing Activity by a Combination of Recombinant DNA Technology and a Cysteine-specific Cyanylation Reaction
• IDENTIFICATION OF A CORTISTATIN-LIKE PEPTIDE IN HUMAN
• Determination of Disulfide Bonds in Recombinant EG-VEGF/Prokineticin 1
• 新しい天然生理活性物質の研究--天然由来ペプチド研究の動向(総説シリ-ズ--現代医学の焦点-46-)
• New Protecting Groups for the Indole Ring of Tryptophan in Peptide Synthesis : 2,4,6-Trimethoxybenzenesulfonyl and 4-Methoxy-2,3,6-trimethylbenzenesulfonyl Groups
• Synthesis of immunologically Active Muramyl Dipeptide Derivatives containing a Quinonyl Moiety via Aminoacyl Intermediates
• Muramyl Dipeptide(MDP)誘導体の合成と免疫アジュバント活性
• Novel Quinonyl Derivatives of Muramyl Dipeptide Possessing Potent Antitumor Activity
• Synthesis of the Nonatetracontapeptide corresponding to the Sequence proposed for Thymopoietin II
• 創薬科学賞受賞 インスリン抵抗性改善薬ピオグリタゾンの創製
• MCHレセプターおよびそのアンタゴニスト (特集 肥満症の分子メカニズム--アディポサイエンス最前線)
• ゲノム情報を活用した21世紀の創薬
• 創薬技術はどこまで進むか (21世紀の医療と創薬--これからの医療・薬物療法はどう変わるか) -- (第2章 21世紀の創薬と薬物療法)
• 薬のディスカバリーはどのように行われるか (特集 新しい医薬品をどう創り,どう評価するか)
• 21世紀の創薬
• 画期的な新薬の研究開発(新薬開発体制における戦略的展開)
• 技術賞受賞アンジオテンシンII受容体拮抗薬カンデサルタンシレキセチルの創製
• ゲノム研究と創薬の可能性(ゲノム科学と医療)
• 遺伝子研究と創薬
• 技術賞受賞トロンボキサンA_2受容体拮抗薬セラトロダストの創製研究
• 第17回ペプチド化学討論会
• 新規オーファン受容体のリガンド-プロラクチン放出ペプチド(PrRP)の発見-
• エンドセリン遺伝子のクロ-ニング
• 第18回ペプチド化学討論会
• Synthesis of a Wasp Venom Tetradecapeptide, Mastoparan, with a New Cleaving System for 4-Methoxy-2,3,6-trimethylbenzenesulfonyl (Mtr) Amino-Protecting Group
• リュープリン(LH-RH super-agonist)の研究開発 (最先端創薬--戦略的アプローチと先端的医薬品) -- (先端的医薬品--単一成分に対するアプローチ)
• リュ-プリン(高活性LH-RH誘導体)の研究開発 (生命科学を指向したペプチド合成の進歩)
• ペプチドから非ペプチドへ
• ポストゲノム時代を迎えた医薬品研究開発
• オーファン受容体のリガンド探索とゲノム創薬 (特集 薬理ゲノミックスとゲノム創薬戦略--日本薬学会第120年会より)
• Synthetic Studies on Enkephalin Analogs. III. A Highly Potent Enkephalin Analog, H-Tyr-D-Met (O)-Gly-Phe-NHNH-CO-CH_2CH_3
• 胸腺ペプチドの合成と免疫活性
• Synthesis of the Nonacosapeptide corresponding to the Proposed Amino Acid Sequence of Turkey Glucagon
• Structure-Taste Relationships of L-Aspartyl-Aminomalonic Acid Diesters
• リュープリン (高活性LH-RH誘導体) の研究開発
• Muramyl Dipeptide (MDP) 誘導体の合成と免疫アジュバント活性
• A New Procedure for the Pentachlorophenylation of N-Protected Amino Acids
• A New Reagent for the tert-Butyloxycarbonylation of Amino Acids
• Synthetic Studies on Enkephalin Analogs. II. Enhanced Analgesic Activity of H-Tyr-D-Ala-Gly-Phe-NHNH-CO-CH_2CH_3 following N-Methylation of Tyr and Phe
• Synthetic Studies on Enkephalin Analogs. I. Potent Analgesic Activity of H-Tyr-D-Ala-Gly-Phe-NHNH-CO-R (R=Lower Alkyl)
• ペプチドの医薬品への応用 (アミノ酸・核酸特集)
• Synthesis of a Highly Potent Analog of Luteinizing Hormone Releasing Hormone (LH-RH) : [Des-Gly-NH_2^, Pro-NH-Et^9]-LH-RH
• Isobornyloxycarbonyl Function, a New Convenient Amino-Protecting Group in Peptide Synthesis. II. Synthesis of Bradykinin
• 生理活性ペプチドの合成
• ゲノム創薬の展望
• 創薬の移り変わり

もっと見る 閉じる

スポンサーリンク